Show Summary Details
Page of

Dextropropoxyphene 

Dextropropoxyphene
Chapter:
Dextropropoxyphene
Author(s):

Paul Glare

DOI:
10.1093/med/9780199236640.003.0008
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 November 2019

Chapter 8 discusses Dextropropoxyphene (DPP), known as propoxyphene in the USA, which is a synthetic weak opioid analgesic of the diphenylpropylamine class, which is derived from the synthetic strong opioid methadone. It is an increasingly controversial drug. DPP is a base, with a pKa of 6.3. It has an active metabolite norpropoxyphene (NPP) which is a non-opioid. The chapter also covers viewpoints of both those who advocate and oppose its use.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.